Thursday, September 28, 2023
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Nurse Practitioner
Helen Diller Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California, United States
Adult Care Nurse Practitioner
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Director, Nursing School
European Institute of Oncology
Professor of Nursing
University of Milan
Milan, Italy
Consultant Nurse
Imperial College Healthcare NHS Trust
London, United Kingdom
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
This activity is intended for non-UK nurses, nurse practitioners, and physician assistants.
The goal of this activity is that learners will be better able to educate nurses on best practices for monitoring and communication in order to improve adherence and persistence in patients with hormone receptor (HR)-positive, human epidermal growth factor 2 (HER2)-negative early breast cancer (EBC) who are being treated with adjuvant therapy.
Upon completion of this activity, participants will:
Medscape, LLC requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients.
All relevant financial relationships for anyone with the ability to control the content of this educational activity are listed below and have been mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Disclosures for additional planners can be found here.
Nurse Practitioner
Helen Diller Comprehensive Cancer Center
University of California, San Francisco
San Francisco, California, United States
Adult Care Nurse Practitioner
Memorial Sloan-Kettering Cancer Center
New York, New York, United States
Director, Nursing School
European Institute of Oncology
Professor of Nursing
University of Milan
Milan, Italy
Consultant Nurse
Imperial College Healthcare NHS Trust
London, United Kingdom
This activity has been peer reviewed and the reviewer has no relevant financial relationships.
Awarded 0.50 contact hour(s) of continuing nursing education for RNs and APNs; 0.50 contact hours are in the area of pharmacology.
For questions regarding the content of this activity, contact the accredited provider for this CME/CE activity noted above. For technical assistance, contact [email protected]
There are no fees for participating in or receiving credit for this online educational activity. For information on applicability
and acceptance of continuing education credit for this activity, please consult your professional licensing board.
This activity is designed to be completed within the time designated on the title page; physicians should claim only those
credits that reflect the time actually spent in the activity. To successfully earn credit, participants must complete the
activity online during the valid credit period that is noted on the title page. To receive
AMA PRA Category 1 Credit™, you must receive a minimum score of 75% on the post-test.
Follow these steps to earn CME/CE credit*:
You may now view or print the certificate from your CME/CE Tracker. You may print the certificate but you cannot alter it.
Credits will be tallied in your CME/CE Tracker and archived for 6 years; at any point within this time period you can print
out the tally as well as the certificates from the CME/CE Tracker.
*The credit that you receive is based on your user profile.
CE Released: 9/22/2022
Valid for credit through: 9/22/2023, 11:59 PM EST
processing....
